 Dysbiosis
"Dysbiosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Changes in quantitative and qualitative composition of MICROBIOTA. The changes may lead to altered host microbial interaction or homeostatic imbalance that can contribute to a disease state often with inflammation.
| Descriptor ID |
D064806
|
| MeSH Number(s) |
C23.550.308
|
| Concept/Terms |
Dysbiosis- Dysbiosis
- Dysbioses
- Disbiosis
- Disbioses
- Dys-symbiosis
- Dys symbiosis
- Dys-symbioses
Dysbacteriosis- Dysbacteriosis
- Dysbacterioses
- Disbacteriosis
- Disbacterioses
|
Below are MeSH descriptors whose meaning is more general than "Dysbiosis".
Below are MeSH descriptors whose meaning is more specific than "Dysbiosis".
This graph shows the total number of publications written about "Dysbiosis" by people in this website by year, and whether "Dysbiosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 | | 2014 | 0 | 1 | 1 | | 2015 | 1 | 0 | 1 | | 2016 | 6 | 1 | 7 | | 2017 | 4 | 0 | 4 | | 2018 | 6 | 3 | 9 | | 2019 | 2 | 5 | 7 | | 2020 | 1 | 3 | 4 | | 2021 | 4 | 4 | 8 | | 2022 | 3 | 4 | 7 | | 2023 | 1 | 2 | 3 | | 2024 | 3 | 2 | 5 | | 2025 | 3 | 7 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Dysbiosis" by people in Profiles.
-
Wilburn AN, Korkmaz RÜ, McAlees JW, Hargis JM, Shirdel S, Lingel I, Watanabe-Chailland M, Romick-Rosendale L, Schmudde I, Bridges JP, Chougnet CA, Deshmukh H, Zacharias WJ, Köhl J, Konig P, Laumonnier Y, Rothenberg M, Haslam DB, Lewkowich IP. Maternal antibiotic exposure-mediated alterations in basal, and allergen-induced lung function are associated with altered recruitment of eosinophils to the developing lung. Front Immunol. 2025; 16:1715675.
-
Knoll RL, Brauny MM, Robert E, Cloos L, Waser L, Hilbert K, Ulmer N, Hillen B, Birkner T, Bartolomaeus TUP, Nitsche O, Jarquín-Díaz VH, Lynch S, Gehring S, Maier L, Poplawska K, Forslund-Startceva SK. CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial. Nat Commun. 2025 Nov 18; 16(1):10111.
-
Flammer ER, Christopher MW, Powers ER, Broncucia H, Steck AK, Gitelman SE, Garrett TJ, Ismail HM. Serum Metabolomics Reveals Potential Differences in Gut Microbiota-Associated Metabolites in Twins Discordant for Type 1 Diabetes. Diabetes. 2025 Nov 01; 74(11):1957-1963.
-
Hazime H, Ducasa GM, Santander AM, Brito N, Gonzalez-Horta EE, Quintero MA, Barnes S, Wilson L, Zhang Y, Yu F, Gharaibeh RZ, Jobin C, Faust KM, Damas OM, Deshpande A, Kerman DH, Proksell S, Pignac-Kobinger J, Fernández I, Burgueño JF, Abreu MT. DUOX2 activation drives bacterial translocation and subclinical inflammation in IBD-associated dysbiosis. Gut. 2025 Sep 08; 74(10):1589-1601.
-
Kuhn KA, Yomogida K, Knoop K, Wu HJ, Zaiss MM. More than a leaky gut: how gut priming shapes arthritis. Nat Rev Rheumatol. 2025 Sep; 21(9):513-525.
-
Ortiz AM, Castello Casta F, Bodykevich EG, Flynn JK, Fennessey CM, Brooks K, Ruiz D, Yee DS, Simpson J, Rahmberg AR, Keele BF, Brenchley JM. Repeated enema administration in rhesus macaques is not sufficient to promote bacterial dysbiosis or gastrointestinal dysfunction. Mucosal Immunol. 2025 Oct; 18(5):1036-1046.
-
Shukla A, Sharma C, Malik MZ, Singh AK, Aditya AK, Mago P, Ray AK. Deciphering the tripartite interaction of urbanized environment, gut microbiome and cardio-metabolic disease. J Environ Manage. 2025 Mar; 377:124693.
-
Abi-Aad SJ, Lovell M, Khalaf RT, Sokol RJ. Pathogenesis and Management of Intestinal Failure-Associated Liver Disease. Semin Liver Dis. 2025 Mar; 45(1):66-80.
-
McMahan RH, Boe D, Giesy LE, Najarro KM, Khair S, Walrath T, Frank DN, Kovacs EJ. Advanced Age Worsens Respiratory Function and Pulmonary Inflammation After Burn Injury and This Correlates With Changes in the Fecal Microbiome in Mice. J Burn Care Res. 2025 01 24; 46(1):53-60.
-
Thibaut MM, Roumain M, Piron E, Gillard J, Loriot A, Neyrinck AM, Rodriguez J, Massart I, Thissen JP, Huot JR, Pin F, Bonetto A, Delzenne NM, Muccioli GG, Bindels LB. The microbiota-derived bile acid taurodeoxycholic acid improves hepatic cholesterol levels in mice with cancer cachexia. Gut Microbes. 2025 Dec; 17(1):2449586.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|